Your future options are larger, oraler, and cheaper than what is in your medicine cabinet right now
This wont bring a $1,300/month medication down to $200, but it can take the edge off retail pricing when other options arent available or accessible in your area
FIGURE 4 PAPR-1 Inhibits LXR-Induced ABCA1 Transcription in INS-1 Cells The potential inhibition of LXR-induced ABCA1 expression by PARP-1 in INS-1 cells was investigated
LDL cholesterol, the so-called bad cholesterol, shows meaningful reductions though not as dramatic as triglycerides
What's Next: Upcoming Readouts in 2026 TRIUMPH-1 (pivotal obesity) on May 21, 2026 (up to -30.3% at 104 weeks), and TRIUMPH-2 and TRIUMPH-3 together on July 23, 2026 (-20.8% and -22.6% at 12 mg)